Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiome dysbiosis and cancer: A systematic review on the emerging role of probiotics in oncology.

Critical reviews in oncology/hematology·2026
Same author

Living in your own skin. The experience of the body in melanoma patients: a systematic literature review.

Italian journal of dermatology and venereology·2026
Same author

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed.

Therapeutic advances in medical oncology·2026
Same author

Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies.

The journal of liquid biopsy·2026
Same author

PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myeloma.

Cancer cell international·2026
Same author

Pituitary hormone deficiencies in prolactinomas: prevalence, predictors, and functional recovery.

Frontiers in endocrinology·2025

Related Experiment Video

Updated: Nov 15, 2025

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.4K

Second medical opinion in oncological setting.

Marco Maruzzo1, Nicla La Verde2, Antonio Russo3

  • 1Oncologia 1, Istituto Oncologico Veneto, IOV - IRCCS, Padova, Italy.

Critical Reviews in Oncology/Hematology
|March 6, 2021
PubMed
Summary

Patients often seek second medical opinions for cancer treatment confidence, but this can cause delays or incorrect advice. This paper explores the benefits, drawbacks, and outcomes of second opinions in oncology.

Keywords:
AIOMDecalogueEthicsMeetingSecond medical opinions

More Related Videos

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
04:45

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

Published on: May 10, 2021

4.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.9K

Related Experiment Videos

Last Updated: Nov 15, 2025

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.4K
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
04:45

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

Published on: May 10, 2021

4.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.9K

Area of Science:

  • Oncology
  • Medical Ethics

Background:

  • Oncological patients increasingly seek second medical opinions for treatment confidence.
  • Physicians also request second opinions for rare tumors and diagnostic discrepancies in radiology and pathology.
  • The role of second opinions in general medical/surgical conditions is less established.

Purpose of the Study:

  • To analyze the reasons, limitations, advantages, and outcomes of second medical opinions in oncology.
  • To address the growing trend of second opinion requests in cancer care.
  • To present a Decalogue (set of ten principles) regarding second opinions in the oncological setting.

Main Methods:

  • This position paper is based on discussions from the 7th Annual Meeting on Ethics in Oncology.
  • It synthesizes existing literature, which is noted as being sparse and often focused on patient motivations.
  • The paper presents a comprehensive overview of the second opinion phenomenon in oncology.

Main Results:

  • Second opinions can increase patient confidence but risk incorrect advice and treatment delays.
  • Discrepancy rates are notable in radiology and pathology settings.
  • The paper outlines key considerations for implementing and utilizing second opinions effectively.

Conclusions:

  • Second medical opinions are a significant aspect of modern oncological care, requiring careful consideration of potential benefits and risks.
  • Further research is needed to fully establish the role and impact of second opinions beyond oncology.
  • The AIOM and AIOM Foundation emphasize the importance of informed decision-making through a structured approach to second opinions.